Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Intelligence-Generated Electronic Medical Record Summarization in Breast Surgical Oncology.

Annals of surgical oncology·2026
Same author

Worsening frailty and declining quality of life in older survivors of non-metastatic breast cancer.

Journal of the National Cancer Institute·2026
Same author

Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.

Journal of the National Cancer Institute·2026
Same author

Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2-Positive Breast Cancer: A Secondary Analysis of the DAPHNe Trial.

JAMA oncology·2026
Same author

ASO Visual Abstract: From Clinical Trial Awareness to Practice-Factors Associated with Intent to Omit Axillary Surgery Based on the SOUND Clinical Trial.

Annals of surgical oncology·2026
Same author

Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancer.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Feb 18, 2026

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.6K

Lobular Breast Cancer: Different Disease, Different Algorithms?

Anita Mamtani1, Tari A King2

  • 1Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Surgical Oncology Clinics of North America
|November 15, 2017
PubMed
Summary

Invasive lobular carcinoma (ILC), a common breast cancer subtype, presents unique characteristics and a favorable prognosis. However, ILC may recur late and respond differently to therapies.

Keywords:
Aromatase inhibitorsBreast conservationChemotherapyE-cadherinInvasive lobular carcinomaMastectomyThe Cancer Genome Analysis

More Related Videos

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

1.0K
Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
15:48

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

23.3K

Related Experiment Videos

Last Updated: Feb 18, 2026

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.6K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

1.0K
Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
15:48

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

23.3K

Area of Science:

  • Oncology
  • Pathology

Background:

  • Invasive lobular carcinoma (ILC) is the second most prevalent form of breast cancer.
  • ILC is characterized by E-cadherin loss, estrogen receptor positivity, HER2 negativity, and low-to-intermediate grade.
  • Despite a generally favorable prognosis, ILC exhibits a propensity for late recurrences and unusual metastatic patterns.

Purpose of the Study:

  • To outline the unique pathogenesis and clinical biology of ILC.
  • To highlight diagnostic challenges posed by ILC's infiltrative nature.
  • To discuss emerging data on ILC's differential response to standard treatments.

Main Methods:

  • Review of existing literature on ILC.
  • Analysis of clinical and pathological features of ILC.
  • Synthesis of emerging data regarding therapeutic responses in ILC.

Main Results:

  • ILC exhibits distinct molecular and histological features compared to other breast cancers.
  • The infiltrative growth pattern of ILC can complicate diagnosis.
  • ILC may show variable responses to conventional breast cancer therapies.

Conclusions:

  • ILC represents a distinct clinical and biological entity within breast cancer.
  • Understanding ILC's unique characteristics is crucial for diagnosis and treatment.
  • Further research is needed to optimize therapeutic strategies for ILC.